SCYNEXIS INC (SCYX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 50M 100M 150M Q1 '13: 4.8M Q2 '13: 4.2M Q3 '13: 4.2M Q4 '13: 3.7M Q1 '14: 4.7M Q2 '14: 65K Q3 '14: 61K Q4 '14: 1.1M Q1 '15: 65K Q2 '15: 64K Q3 '15: 64K Q4 '15: 64K Q1 '16: 64K Q2 '16: 64K Q3 '16: 64K Q4 '16: 65K Q1 '17: 64K Q2 '17: 64K Q3 '17: 64K Q4 '17: 64K Q1 '18: 64K Q2 '18: 64K Q3 '18: 64K Q4 '18: 64K Q1 '19: 64K Q2 '19: 57K Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q1 '21: 12.1M Q2 '21: 0 Q3 '21: 516K Q4 '21: 597K Q1 '22: 687K Q2 '22: 1.3M Q3 '22: 1.6M Q4 '22: 1.5M Q1 '23: 1.1M Q2 '23: 131.5M Q3 '23: 1.8M Q4 '23: 5.8M Q1 '24: 1.4M Q2 '24: 736K Q3 '24: 660K Q4 '24: 977K Q1 '25: 257K Q2 '25: 1.4M Q3 '25: 334K Q4 '25: 18.6M Q1 '26: 0 Q2 '26: 235K Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Gross Profit Quarterly

-600K 0 600K 1.2M 1.8M Q1 '13: 647K Q2 '13: -171K Q3 '13: 177K Q4 '13: -101K Q1 '14: 745K Q2 '14: 462K Q3 '14: 720K Q4 '14: 1.7M Q1 '15: 66K Q1 '13 Q3 '13 Q1 '14 Q3 '14 Q1 '15

Operating Income Quarterly

-40M 0 40M 80M 120M Q1 '13: -1.1M Q2 '13: -1.6M Q3 '13: -2M Q4 '13: -2.5M Q1 '14: -1.8M Q2 '14: -4M Q3 '14: -4.5M Q4 '14: -3.6M Q1 '15: -5.9M Q2 '15: -6.5M Q3 '15: -7.5M Q4 '15: -8.4M Q1 '16: -7.2M Q2 '16: -8.3M Q3 '16: -6.7M Q4 '16: -5.6M Q1 '17: -6M Q2 '17: -6.7M Q3 '17: -6.4M Q4 '17: -7.2M Q1 '18: -7.2M Q2 '18: -7.7M Q3 '18: -6.3M Q4 '18: -8.8M Q1 '19: -11.9M Q2 '19: -11.2M Q3 '19: -11.8M Q4 '19: -14.1M Q1 '20: -12.5M Q2 '20: -11.8M Q3 '20: -11.5M Q4 '20: -15.3M Q1 '21: -1.6M Q2 '21: -17.5M Q3 '21: -19.4M Q4 '21: -22.3M Q1 '22: -19.7M Q2 '22: -21.7M Q3 '22: -21.8M Q4 '22: -22.5M Q1 '23: -10.7M Q2 '23: 116.5M Q3 '23: -10.1M Q4 '23: -23.1M Q1 '24: -9.5M Q2 '24: -9.2M Q3 '24: -10.3M Q4 '24: -8.1M Q1 '25: -8.6M Q2 '25: -9.6M Q3 '25: -8.4M Q4 '25: 10.5M Q1 '26: -16.9M Q2 '26: -7.8M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Net Income Quarterly

-50M 0 50M 100M 150M Q1 '13: -2.1M Q2 '13: -2.7M Q3 '13: -4M Q4 '13: -21.7M Q1 '14: 412K Q2 '14: 2.2M Q3 '14: -3.8M Q4 '14: -3.1M Q1 '15: -6.4M Q2 '15: -9.5M Q3 '15: -8.4M Q4 '15: -8.4M Q1 '16: -7.2M Q2 '16: -8.1M Q3 '16: -11.2M Q4 '16: -3.4M Q1 '17: -4.9M Q2 '17: -4.2M Q3 '17: -8.4M Q4 '17: -7.6M Q1 '18: -4M Q2 '18: -10.8M Q3 '18: 351K Q4 '18: 1.9M Q1 '19: -22.9M Q2 '19: -8.4M Q3 '19: -7.9M Q4 '19: -14.5M Q1 '20: -7M Q2 '20: -6.4M Q3 '20: 909K Q4 '20: -42.7M Q1 '21: -4.7M Q2 '21: 1.7M Q3 '21: -605K Q4 '21: -29.2M Q1 '22: -5.5M Q2 '22: -13.3M Q3 '22: -29.6M Q4 '22: -14.4M Q1 '23: -33.9M Q2 '23: 122.3M Q3 '23: -1.8M Q4 '23: -19.6M Q1 '24: 411K Q2 '24: -14.5M Q3 '24: -2.8M Q4 '24: -4.4M Q1 '25: -5.4M Q2 '25: -6.9M Q3 '25: -8.6M Q4 '25: 12.3M Q1 '26: -21.3M Q2 '26: 7.4M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q1 '13: 4.1M Q2 '13: 4.4M Q3 '13: 4M Q4 '13: 3.8M Q1 '14: 4M Q2 '14: 4.2M Q3 '14: 3.7M Q4 '14: 3.6M Q1 '15: 3.2M Q1 '13 Q3 '13 Q1 '14 Q3 '14 Q1 '15

Operating Cash Flow Quarterly

-30M 0 30M 60M 90M Q1 '13: -1.9M Q2 '13: -982K Q3 '13: -146K Q4 '13: -1.3M Q1 '14: 161K Q2 '14: -4.2M Q3 '14: -3.7M Q4 '14: -1.7M Q1 '15: -4.5M Q2 '15: -8.3M Q3 '15: -5.7M Q4 '15: -6M Q1 '16: -9M Q2 '16: -9M Q3 '16: -6.8M Q4 '16: -4.6M Q1 '17: -6.8M Q2 '17: -7.4M Q3 '17: -5.2M Q4 '17: -5.2M Q1 '18: -8.2M Q2 '18: -7.9M Q3 '18: -6.1M Q4 '18: -6.1M Q1 '19: -6.5M Q2 '19: -7.8M Q3 '19: -10.4M Q4 '19: -13.5M Q1 '20: -14.1M Q2 '20: -8.9M Q3 '20: -9.9M Q4 '20: -16.6M Q1 '21: -759K Q2 '21: -11.7M Q3 '21: -16.6M Q4 '21: -25.5M Q1 '22: -16M Q2 '22: -18.6M Q3 '22: -22.5M Q4 '22: -22.8M Q1 '23: -18.9M Q2 '23: 74.4M Q3 '23: 12.4M Q4 '23: -7.7M Q1 '24: -4M Q2 '24: -10.9M Q3 '24: 765K Q4 '24: -9.9M Q1 '25: -7.5M Q2 '25: -7.5M Q3 '25: -8.7M Q4 '25: 18.4M Q1 '26: -8.1M Q2 '26: -14.9M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Free Cash Flow Quarterly

-27M -18M -9M 0 9M 18M 27M Q1 '13: -2.1M Q2 '13: -1M Q3 '13: -203K Q4 '13: -1.4M Q1 '14: 87K Q2 '14: -4.5M Q3 '14: -4M Q4 '14: -1.8M Q1 '15: -4.7M Q2 '15: -8.6M Q3 '15: -5.8M Q4 '15: -6M Q1 '16: -9M Q2 '16: -9M Q3 '16: -6.9M Q4 '16: -4.6M Q1 '17: -6.8M Q2 '17: -7.4M Q3 '17: -5.2M Q4 '17: -5.2M Q1 '18: -8.2M Q2 '18: -8.3M Q3 '18: -6.2M Q4 '18: -6.1M Q1 '19: -6.5M Q2 '19: -7.8M Q3 '19: -10.4M Q4 '19: -13.5M Q1 '20: -14.1M Q2 '20: -8.9M Q3 '20: -9.9M Q4 '20: -16.6M Q1 '21: -759K Q2 '21: -11.7M Q3 '21: -16.6M Q4 '21: -25.5M Q1 '13 Q2 '14 Q3 '15 Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '13: 335.8K Q2 '13: 335.9K Q3 '13: 335.9K Q1 '14: 609.1K Q2 '14: 5.5M Q3 '14: 8.5M Q1 '15: 8.5M Q2 '15: 12.2M Q3 '15: 13.9M Q1 '16: 13.9M Q1 '17: 25.6M Q3 '17: 27.1M Q1 '18: 33.6M Q3 '18: 47M Q3 '19: 6.7M Q1 '20: 9.7M Q2 '20: 10M Q3 '20: 13.4M Q1 '21: 26.5M Q2 '21: 26.5M Q3 '21: 27.8M Q1 '22: 33.2M Q2 '22: 43.3M Q3 '22: 47.5M Q1 '23: 47.8M Q2 '23: 49.9M Q3 '23: 47.9M Q1 '24: 48.6M Q2 '24: 48.5M Q3 '24: 48.6M Q1 '25: 49.4M Q2 '25: 6.2M Q3 '25: 49.9M Q1 '26: 51M Q2 '26: 11.8M Q2 '14 Q1 '16 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-150.00 -100.00 -50.00 0.00 50.00 100.00 150.00 Q4 '13: -139.48 Q4 '15: -2.72 Q1 '16: -2.49 Q2 '16: -2.27 Q3 '16: -2.15 Q4 '16: -1.58 Q1 '17: -1.31 Q2 '22: -1.07 Q3 '22: -1.63 Q4 '22: -1.40 Q1 '23: -1.93 Q2 '23: 0.84 Q3 '23: 1.42 Q4 '23: 1.39 Q1 '24: 2.11 Q2 '24: -0.65 Q3 '24: -0.67 Q4 '24: -0.44 Q1 '25: -0.56 Q2 '25: -1.37 Q3 '25: -1.48 Q1 '16 Q4 '16 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.